Cell-type-specific mechanisms implicated in mRNA translation and memory in Alzheimer's disease

Rogers Koboji, Department of Biomedical Sciences, University of Windsor
Maria Badalova, Department of Biomedical Sciences, University of Windsor
Maya Reeves, Department of Biomedical Sciences, University of Windsor
Vijendra Sharma, Department of Biomedical Sciences, University of Windsor

Description

mRNA translation in the brain is necessary for long-term memory consolidation, and its dysregulation is implicated in memory loss in Alzheimer’s disease. Pathological features of Alzheimer’s disease include the accumulation of amyloid-beta peptides and hyperphosphorylated tau proteins. The accumulation of these proteins results in many stressors that trigger the integrated stress response, which phosphorylates the α subunit of eukaryotic initiation factor 2 (p-eIF2α), inhibiting general protein synthesis. Prolonged integrated stress response activation in Alzheimer’s disease increases p-eIF2α levels, downregulates general protein synthesis, and impairs long-term memory consolidation. p-eIF2α is a key translational control mechanism to bidirectionally control long-term memory in health and disease. Learning stimulates general protein synthesis in a healthy brain by dephosphorylation of p-eIF2α. Cell-type-specific suppression of the integrated stress response in mice models of translation rescued memory deficit. However, the cell-type-specific translation regulation mechanisms are less understood in Alzheimer’s disease. Our objectives are to identify the cell-types with dysregulated mRNA translation in Alzheimer's disease and to restore translation in those cell-types to assess there effects on memory in Alzheimer's disease. To this end, Alzheimer's disease mice will be immuno-stained for p-eIF2α and eIF2α in specific cell-types, and eIF2α will be knocked-in to suppress the integrated stress response. Thus far, we introduced knocked-in eIF2α into the Alzheimer’s disease mice astrocytes and observed that stimulating translation in astrocytes can rescue memory deficits. Dissecting cell-type-specific translational control mechanisms in Alzheimer’s can aid in developing therapeutics to target specific cell populations, potentially leading to better treatment outcomes for Alzheimer’s disease.

 
Mar 22nd, 11:00 AM Mar 22nd, 5:30 PM

Cell-type-specific mechanisms implicated in mRNA translation and memory in Alzheimer's disease

mRNA translation in the brain is necessary for long-term memory consolidation, and its dysregulation is implicated in memory loss in Alzheimer’s disease. Pathological features of Alzheimer’s disease include the accumulation of amyloid-beta peptides and hyperphosphorylated tau proteins. The accumulation of these proteins results in many stressors that trigger the integrated stress response, which phosphorylates the α subunit of eukaryotic initiation factor 2 (p-eIF2α), inhibiting general protein synthesis. Prolonged integrated stress response activation in Alzheimer’s disease increases p-eIF2α levels, downregulates general protein synthesis, and impairs long-term memory consolidation. p-eIF2α is a key translational control mechanism to bidirectionally control long-term memory in health and disease. Learning stimulates general protein synthesis in a healthy brain by dephosphorylation of p-eIF2α. Cell-type-specific suppression of the integrated stress response in mice models of translation rescued memory deficit. However, the cell-type-specific translation regulation mechanisms are less understood in Alzheimer’s disease. Our objectives are to identify the cell-types with dysregulated mRNA translation in Alzheimer's disease and to restore translation in those cell-types to assess there effects on memory in Alzheimer's disease. To this end, Alzheimer's disease mice will be immuno-stained for p-eIF2α and eIF2α in specific cell-types, and eIF2α will be knocked-in to suppress the integrated stress response. Thus far, we introduced knocked-in eIF2α into the Alzheimer’s disease mice astrocytes and observed that stimulating translation in astrocytes can rescue memory deficits. Dissecting cell-type-specific translational control mechanisms in Alzheimer’s can aid in developing therapeutics to target specific cell populations, potentially leading to better treatment outcomes for Alzheimer’s disease.

https://scholar.uwindsor.ca/we-spark-conference/2025/postersessions/38